PATENT CLAIM ANALYSIS

Application Number: 16315710
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["514", "235200"]

Abstract:
The present invention relates to a compound of the formula: where n, R and R are those defined herein. The present invention also relates to use of a compound of Formula 1 in treating a clinical condition associated with fibrotic disorder.

Claim (Index 16):
The compound of  claim 1 , wherein the compound is N-(2-(indolin-1-yl)propyl)-4-(trifluoromethoxy)benzenesulfonamide N-(2-(indolin-1-yl)propyl)-4-(trifluoromethyl)benzenesulfonamide N-(2-(indolin-1-yl)propyl)-4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzenesulfonamide N-(2-(indolin-1-yl)ethyl)-4-(trifluoromethyl)benzenesulfonamide N-(2-(indolin-1-yl)ethyl)-4-(trifluoromethoxy)benzenesulfonamide N-(2-(indolin-1-yl)ethyl)-4-phenoxybenzenesulfonamide N-(2-(indolin-1-yl)ethyl)-4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzenesulfonamide 3,4-difluoro-N-(2-(indolin-1-yl)ethyl)benzenesulfonamide 4-cyano-N-(2-(indolin-1-yl)ethyl)benzenesulfonamide N-(2-(indolin-1-yl)-2-methylpropyl)-4-(trifluoromethyl)benzenesulfonamide N-(2-(indolin-1-yl)-2-methylpropyl)-4-phenoxybenzenesulfonamide N-(2-(indolin-1-yl)-2-methylpropyl)-4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzenesulfonamide N-(2-(indolin-1-yl)-2-methylpropyl)-4-methoxybenzenesulfonamide N-(2-(indolin-1-yl)-2-methylpropyl)-4-(trifluoromethoxy)benzenesulfonamide N-(2-(indolin-1-yl)ethyl)pyrrolidine-1-carboxamide N-(N,N-diethylaminosulfonyl)-2-(indolin-1-yl)-2-methylpropane-1-amine 1-(2-(4-((4-fluorophenyl)sulfonyl)piperazin-1-yl)ethyl)indoline 1-(2-(4-((4-(trifluoromethoxy)phenyl)sulfonyl)piperazin-1-yl)ethyl)indoline N,N-diethyl-4-(2-(indolin-1-yl)ethyl)piperazine-1-sulfonamide or a pharmaceutically acceptable salt thereof. The compound of  claim 1 , wherein the compound is N-(2-(indolin-1-yl)ethyl)-4-phenoxybenzenesulfonamide N-(2-indolin-1-yl)ethyl)4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzenesulfonamide 3,4-difluoro-N-(2-(indolin-1-yl)ethyl)benzenesulfonamide 4-cyano-N-(2-(indolin-1-yl)ethyl)benzenesulfonamide or a pharmaceutically acceptable salt thereof. The compound of  claim 1 , wherein the compound is 1-(2-(4-((4-(trifluoromethoxy)phenyl)sulfonyl)piperazin-1-yl)ethyl)indoline N,N-diethyl-4-(2-(indolin-1-yl)ethyl)piperazine-1-sulfonamide. 1-(2-(4-((4-fluorophenyl)sulfonyl)piperazin-1-yl)ethyl)indoline or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15736450', '14000829', '15315461', '15738900', '10516681']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7274175932525164
- 35 USC 102 Novelty (BERT): 0.5006632421991716
- Combined Prediction Score: 0.704742158147182
- Mean Citation Score: 234.662008
- Max Citation Score: 248.7203
- Similarity Product: 202.05117616397143

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test